Teva Pharmaceutical reported 734M in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aspen Pharmacare APN:SJ 479.9B 476B
Cipla CIPLA:IN 8.89B 4.3B
Dr.Reddys Laboratories DRRD:IN 6.39B 2.6B
Guangzhou Baiy 600332:CH 1.06B 1.03B
Jiangsu Hengrui Me. 600276:CH 834.02M 438.25M
Kalbe Farma Tbk Pt KLBF:IJ 976.21B 77.06B
Richter Gedeon RICHT:HB 43.45B 5.99B
Sh Fosun Pharma 600196:CH 1.19B 340.52M
Sun Pharmaceuticals SUNP:IN 21.51B 5.28B
Teva Pharmaceutical TEVA:IT 734M 55M